|
⚲
|
| Keyboard |
| venBio Select Advisor LLC
✚
|
|
|---|---|
| CIK # | 0001633313 |
| CIK | Period |
|---|---|
| 0001633313 |
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| United Therapeutics Corp | 1.8 | ||
| Ascendis Pharma A/S | 1.2 | ||
| Synta Pharmaceuticals Corp | 1.0 | ||
| Krystal Biotech Inc | 0.7 | ||
| Argenx SE | 0.7 | ||
| Arrowhead Research Corp | 0.7 | ||
| Kymera Therapeutics Inc | 0.6 | ||
| Celcuity Inc | 0.4 | ||
| Xenon Pharmaceuticals Inc | 0.3 | ||
| Structure Therapeutics Inc | 0.3 | ||
| Vera Therapeutics Inc | 0.2 | ||
| Revolution Medicines Inc | 0.2 | ||
| Cytokinetics Inc | 0.2 | ||
| Ocular Therapeutix Inc | 0.1 | ||
| Galecto Inc | 0.1 | ||
| Uniqure NV | 0.1 | ||
| Taysha Gene Therapies Inc | 0.1 | ||
| MIND Medicine Mindmed Inc | 0.1 | ||
| Alkermes PLC | 0.0 | ||
| Septerna Inc | 0.0 | ||
| Signal Genetics Inc | 0.0 | ||
| GH Research PLC | 0.0 | ||
| Cerecor Inc | 0.0 | ||
| Lexeo Therapeutics Inc | 0.0 | ||
| Zeta Acquisition Corp II | 0.0 | ||
| Mannkind Corp | 0.0 | ||
| Prev | Page 1 | Next | |||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001633313] | |
| 3 | [0001633313] | |
| 4 | [0001633313] | |
| SC 13D | [0001633313] | |
| SC 13G | [0001633313] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Avoro Ventures LLC | |
| Aghazadeh Behzad | |
| Avoro Capital Advisors LLC | |
| Zeta Acquisition Corp II | |
| CymaBay Therapeutics Inc | |
| Immunomedics Inc | |
| Mirati Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Zeta Acquisition Corp II WHWK
Stock Option (right to buy) · derivative
|
2025-06-12 | Grant | 40,006 | $0.00 | |
|
Zeta Acquisition Corp II AADI
Pre-funded Warrant (right to buy) · derivative
|
2025-02-28 | Grant | 8,333,000 | $2.40 | 19,999,200 |
|
Zeta Acquisition Corp II AADI
Stock Option (right to buy) · derivative
|
2024-06-12 | Grant | 45,832 | $0.00 | |
|
CymaBay Therapeutics Inc CBAY
Put Option (obligation to buy) · derivative
|
2023-09-13 | Sell | 250 | $0.98 | 245 |
|
CymaBay Therapeutics Inc CBAY
Put Option (obligation to buy) · derivative
|
2023-09-13 | Sell | 950 | $1.10 | 1,045 |
|
CymaBay Therapeutics Inc CBAY
Put Option (obligation to buy) · derivative
|
2023-09-12 | Sell | 300 | $1.00 | 300 |
|
CymaBay Therapeutics Inc CBAY
Pre-funded Warrant (right to buy) · derivative
|
2023-09-12 | Buy | 583,771 | $17.13 | 9,999,997 |
|
CymaBay Therapeutics Inc CBAY
Put Option (obligation to buy) · derivative
|
2023-09-12 | Sell | 1,500 | $1.00 | 1,500 |
|
Zeta Acquisition Corp II AADI
Stock Option (right to buy) · derivative
|
2023-06-15 | Grant | 28,255 | $0.00 | |
|
CymaBay Therapeutics Inc CBAY
Pre-funded Warrant (right to buy) · derivative
|
2023-01-26 | Buy | 2,142,857 | $7.00 | 14,999,999 |
|
Zeta Acquisition Corp II AADI
"Common Stock, $0.0001 par value per share (""Common Stock"")"
|
2022-09-22 | Grant | 1,260,000 | $12.50 | 15,750,000 |
|
Zeta Acquisition Corp II AADI
Stock Option (right to buy) · derivative
|
2022-06-15 | Grant | 18,573 | $0.00 | |
|
CymaBay Therapeutics Inc CBAY
Pre-funded Warrant (right to buy) · derivative
|
2021-11-22 | Buy | 2,500,000 | $4.00 | 10,000,000 |
|
Zeta Acquisition Corp II AADI
Stock option (right to buy) · derivative
|
2021-08-27 | Grant | 17,549 | $0.00 | |
|
Zeta Acquisition Corp II AADI
"Common Stock, $0.0001 par value per share (""Common Stock"")"
|
2021-08-26 | Grant | 1,911,752 | $13.08 | 25,005,716 |
|
Immunomedics Inc IMMU
Restricted Stock Unit · derivative
|
2020-10-23 | Disposed to issuer | 103,718 | ||
|
Immunomedics Inc IMMU
Common Stock
|
2020-10-23 | Disposed to issuer | 26,250,000 | ||
|
Immunomedics Inc IMMU
Common Stock
|
2020-10-23 | Disposed to issuer | 13,516 | ||
|
Immunomedics Inc IMMU
Stock Option (Right to Buy) · derivative
|
2020-10-23 | Disposed to issuer | 202,614 | ||
|
Immunomedics Inc IMMU
Common Stock, $0.01 par value per share (''Common Stock'')
|
2020-06-18 | Grant | 3,718 | $0.00 | |
| showing 20 of 71 most recent transactions | |||||